https://lnkd.in/fVhgeFB R Moola, R Wong, R Zuckermann, LT Williams, W Shelander, “PROXY ANTIGENS”: A DEFINITIVE TOOL TO IDENTIFY THERAPEUTIC TARGETS. Rusty WilliamsRonald ZuckermannBill ShelanderMuralidhar Reddy MoolaRoger Wong, Ph.D., MBA Alzheimer's & Dementia June 2019 15(7):P1599-P1600 #AnvenBio #clinicaltrial #ProxyAntigen #Antibody #alzheimersdisease #immunooncology https://lnkd.in/dRRBuxy Ronald Zuckermann Keynote Address to the inaugural International Online Peptoid Symposium - peptoid commercialization slide Anven Biosciences, Inc. Circle Pharma, Inc. Maxwell Biosciences #peptoid #therapeutics #commercialization #anvenbio